Citation Impact
Citing Papers
Preferential Generation of Follicular B Helper T Cells from Foxp3 + T Cells in Gut Peyer's Patches
2009 StandoutScienceNobel
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
2014
Development and validation of the Nancy histological index for UC
2015 Standout
Targeted therapies for breast cancer
2011
Disruption of Parallel and Converging Signaling Pathways Contributes to the Synergistic Antitumor Effects of Simultaneous mTOR and EGFR Inhibition in GBM Cells
2005
Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members
2008
Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells
2012
Dual mTORC1/2 and HER2 Blockade Results in Antitumor Activity in Preclinical Models of Breast Cancer Resistant to Anti-HER2 Therapy
2012
Targeting Tyrosine Kinases in Cancer: The Second Wave
2006 Science
Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors
2005
Quantitative Proteomics with siRNA Screening Identifies Novel Mechanisms of Trastuzumab Resistance in HER2 Amplified Breast Cancers
2012
Head and neck squamous cell carcinoma
2020 Standout
Cytokines in inflammatory bowel disease
2014 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
2007 Standout
Role of endoscopy in predicting the disease course in inflammatory bowel disease
2010
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Large-scale gene function analysis with the PANTHER classification system
2013 Standout
Breast cancer
2016 Standout
Comparing antibody and small-molecule therapies for cancer
2006
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Sphingolipids and their metabolism in physiology and disease
2017 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke
2009 StandoutNobel
Anti‐tumor activity of the combination of cetuximab, an anti‐EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases
2006
Correction: CDK4/ 6 inhibition provides a potent adjunct to Her2- targeted therapies in preclinical breast cancer models
2021
Cancer drug resistance: an evolving paradigm
2013 Standout
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions
2015
Epidermal Growth Factor Receptor Targeting in Cancer
2006
Head and neck cancer
2008 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Crohn's disease
2012 Standout
Angiogenesis: an organizing principle for drug discovery?
2007 Standout
Monoclonal antibodies: versatile platforms for cancer immunotherapy
2010
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn’s Disease
2018
Follicular B helper T cells in antibody responses and autoimmunity
2005
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Antibody therapy of cancer
2012 Standout
18F-Fluorodeoxyglucose Positron-Emission Tomography (PET) Can Be Used to Assess Inflammation Non-invasively in Crohn’s Disease
2012
HPV-associated head and neck cancer: a virus-related cancer epidemic
2010 Standout
Mucosal Healing in Inflammatory Bowel Disease: Where Do We Stand?
2010
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Usefulness of transabdominal ultrasonography for assessing ulcerative colitis: a prospective, multicenter study
2018
Ceramide-orchestrated signalling in cancer cells
2012
Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease
2016
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis
2016
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Ulcerative colitis
2016 Standout
Understanding resistance to EGFR inhibitors—impact on future treatment strategies
2010
Targeting the ERBB family in cancer: couples therapy
2013
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
2010
IgG4-related disease
2014 Standout
Clinical implications of mucosal healing for the management of IBD
2009
Ulcerative colitis
2020 Standout
Integration of EGFR inhibitors with radiochemotherapy
2006
Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease
2011
Mucosal Healing in Crohnʼs Disease
2012
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
The PI3K Pathway in Human Disease
2017 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Epidermal growth factor receptor (EGFR) signaling in cancer
2005 Standout
Epidermal Growth Factor Receptor (EGFR) Antibody Down-regulates Mutant Receptors and Inhibits Tumors Expressing EGFR Mutations
2006
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Emerging targeted agents in metastatic breast cancer
2013
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Critical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer
2005
Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck
2007
Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
2014 Standout
KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
2006 Standout
IL-17 and Th17 Cells
2009 Standout
CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models
2014
Molecular Pathology of Head and Neck Cancer: Implications for Diagnosis, Prognosis, and Treatment
2008
Systematic review with meta‐analysis: mucosal healing is associated with improved long‐term outcomes in Crohn's disease
2015
Tumor Growth Inhibition with Cetuximab and Chemotherapy in Non–Small Cell Lung Cancer Xenografts Expressing Wild-type and Mutated Epidermal Growth Factor Receptor
2007
Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer
2007 Standout
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study
2018
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review
2019
RNA-binding protein Musashi family: Roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation
2002
Regulatory roles of IL-10–producing human follicular T cells
2019 StandoutNobel
Cancerous stem cells can arise from pediatric brain tumors
2003 Standout
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study
2005
Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
2012
Works of Sónia Rodríguez being referenced
Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2 + breast cancer patients
2011
Colonic Crohn’s disease: value of magnetic resonance colonography for detection and quantification of disease activity
2009
Spontaneous Congenital Hydrocephalus in the Mutant Mouse hyh. Changes in the Ventricular System and the Subcommissural Organ
1998
Magnetic resonance imaging for evaluation of Crohnʼs disease
2010
Accuracy of Magnetic Resonance Enterography in Assessing Response to Therapy and Mucosal Healing in Patients With Crohn's Disease
2013
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease
2009
546 Validation of a Magnetic Resonance Index of Activity for Ileocolonic Crohn's Disease
2010
Diagnostic accuracy of magnetic resonance colonography for the evaluation of disease activity and severity in ulcerative colitis: a prospective study
2012
Combined Epidermal Growth Factor Receptor Targeting with the Tyrosine Kinase Inhibitor Gefitinib (ZD1839) and the Monoclonal Antibody Cetuximab (IMC-C225)
2004
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma
2013